Boehringer Ingelheim, Evotec and bioMérieux forms JV Aurobac to fight antimicrobial resistance

The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.

AMPEL BioSolutions' predicts drug options with RNA analytics & machine learning

Vaccizone selects Exothera for GMP manufacturing of its SARS?CoV?2 vaccine

Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells

Need for national-level awareness about organ transplant surgeries & organ donation in India

People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.

Sanofi Global Health launches nonprofit Impact brand for 30 medicines in low-income countries

Medicines, including insulin, to be available in 40 lower-income countries

Microsize launched as Independent pharma services company

Meets the growing need for US-based API solubility and bioavailability enhancement services

Clinical study of PD-L1 antibody ASC22 for cure of HIV completes first patient dosing

Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection

Lonza to invest 500 mn in commercial drug product fill & finish facility

The investment will enable the company to provide customers with a complete and integrated end-to-end solution

UK Parliament honours All India Institute of Ayurveda’s Director Dr Tanuja Nesari with Ayurveda Ratna Award

The award was presented to her during a virtual ceremony on the occasion of 8th International Day of Yoga on 21st June 2022.

Ardelyx gets into $20 million financing agreement with HealthCare Royalty Partners

HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States